Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1630 of 5804
-
Brain training for eating disorders: a new hope?
Symptom relief OngoingEating disorders are severe mental illnesses, mainly affecting adolescent- and young adult women. The prognoses for eating disorders are relatively poor, and a large part of patients with these illnesses do not benefit from available conventional therapies. After decades of resea…
Phase: NA • Sponsor: Norwegian University of Science and Technology • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New vaccine combo aims to supercharge immune attack on breast cancer
Disease control TerminatedIn this phase II study, participants will receive the VRP-HER2 immunizations plus pembrolizumab. Subjects will be randomized into 3 arms. They will undergo a biopsy of their tumor and peripheral blood draw for immune cell analyses and be assigned to the applicable arm of the stud…
Phase: PHASE2 • Sponsor: Herbert Lyerly • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Stent-Free strategy shows promise for Rock-Hard heart arteries
Disease control CompletedThe optimal management of severely calcified coronary artery disease remains challenging, particularly in the context of drug-coated balloon (DCB) angioplasty. This study aimed to evaluate the feasibility, safety, and mid-term clinical outcomes of a DCB-only strategy following co…
Sponsor: University of Rome Tor Vergata • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can acupuncture boost brain function in Alzheimer's? new trial aims to find out
Symptom relief Recruiting nowThe objective of this proposed study is to evaluate the effect and safety of acupuncture combined therapy on cognitive function, daily living ability and quality of life of Alzheimer's disease by using the international dementia certification scale. In this 12-week, assessor-blin…
Phase: NA • Sponsor: Jian Pei,MD • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Robotic surgery or radiation? new study compares which is better for throat cancer patients' quality of life
Symptom relief OngoingOropharyngeal squamous cell carcinoma (OPSCC) is now the most frequently diagnosed head and neck cancer in Denmark which is mainly due to the increase of Human Papillomavirus (HPV). Patients with HPV-positive OPSCC have a significantly higher survival rate compared to HPV-negativ…
Phase: NA • Sponsor: Christian von Buchwald • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Extra nerve block helps pancreatic surgery patients leave hospital without opioids
Symptom relief CompletedThis phase II trial studies how an additional anesthetic nerve block, called a quadratus lumborum block, works to reduce the need for opioids in patients after pancreatic surgery. Giving an additional regional anesthetic after surgery may hasten the weaning process, reduce the ne…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Five new drugs aim to tame painful skin condition
Disease control OngoingThe main purpose of this study is to assess preliminary efficacy and safety of CFZ533/iscalimab (Cohort A), LYS006 (Cohort B), MAS825 (Cohort C), LOU064/remibrutinib (Cohort D) and VAY736/ianalumab (Cohort E) in patients with moderate to severe hidradenitis suppurativa and to det…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Dental cleaning could unlock faster sepsis diagnosis
Knowledge-focused OngoingApproximately 40,000 Swedes suffer from sepsiseach year, about 20% die. Biomarkers that are sensitive to current or previous bacteremia are needed in the treatment of sepsis. Bacteremia from periodontal treatment is predictive and occurs in 13-75%. Cardiovascular disease (CVD) is…
Phase: NA • Sponsor: Malmö University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Promising drug tested for rare liver disease in newborns
Disease control CompletedNiemann-Pick disease, type C (NPC) is a lethal, autosomal recessive, lysosomal storage disorder characterized by neurodegeneration in early childhood and death in adolescence. NPC results from mutation of either the Niemann-Pick C1 disease (NPC1) (\~95% of cases) or NPC2 genes. N…
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could fewer antibiotics be better for MAC lung disease?
Disease control CompletedNTM therapy consists of a multi-drug macrolide based regimen for 18-24 months. Treated patients frequently experience debilitating side effects, and many patients delay the start of antibiotic treatment due to these risks. Common side effects include nausea, diarrhea, and fatigue…
Phase: PHASE2, PHASE3 • Sponsor: Kevin Winthrop • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New study tests therapy to stop child abuse before it starts
Prevention CompletedHome visitation by community health workers is a commonly utilized approach to support families and prevent child maltreatment. At times, however, more intensive intervention is needed to address familial trauma, depression, or other challenges. This preventive treatment evaluati…
Phase: NA • Sponsor: University of Rochester • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
Can a cancer drug wipe out hidden tumor cells after surgery?
Disease control OngoingThe purpose of this study is to test the safety of the study drug, pembrolizumab, and to find out how well it works to prevent cancer from coming back in people who have had a solid tumor surgically removed, but still have tumor cells in their blood. During the study, the partici…
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New heart valve device shows promise for High-Risk patients
Disease control OngoingThe study collects real-world data of patients who were treated with the ALLEGRA TAVI System TF and evaluates early and midterm clinical and quality of life outcome.
Sponsor: NVT GmbH • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
DNA blood test could catch ovarian cancer sooner
Diagnosis CompletedThe purpose of this study is to determine if there are markers in plasma that can be used to develop a diagnostic panel for early detection and diagnosis of high grade serous epithelial ovarian cancer.
Sponsor: Baylor Research Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
New hope for kids with Drug-Resistant TB: delamanid studied in children
Disease control CompletedThis Phase I/II study evaluated the pharmacokinetics, safety, and tolerability of the anti-tuberculosis (TB) drug delamanid (DLM) in combination with an optimized multidrug background regimen (OBR) for multidrug-resistant tuberculosis (MDR-TB) in children with MDR-TB with and wit…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Parents and therapists team up to boost walking in kids with stroke
Symptom relief OngoingA prospective, single blind, parallel group, randomized control trial to determine if early, intensive lower extremity activity delivered by a physical therapist and a parent in partnership improves gross motor function more than usual care.
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Could an old antibiotic help Parkinson's dementia?
Disease control CompletedThis is a randomized, double blinded, placebo-controlled Phase II study to investigate the efficacy and safety of ceftriaxone in patients with mild to moderate Parkinson's disease dementia (PDD).This study will enroll approximately 106 patients to have up to 84 evaluable subjects…
Phase: PHASE2 • Sponsor: BrainX Corporation • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Blood test could shorten antibiotic course for newborns with sepsis
Disease control CompletedThe duration of antibiotic (ATB) therapy in late onset sepsis (LOS) of the neonate is currently not based on scientific data. The current PROABIS trial will study the use of a biological marker, procalcitonin (PCT), to guide ATB therapy duration in neonates with LOS. Our hypothe…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 15:44 UTC
-
New pill shows promise against tough breast cancer
Disease control OngoingThe standard or usual treatment for this disease is to undergo chemotherapy to slow the spread of the disease and relieve some symptoms of cancer. Patients will have already had at least one chemotherapy treatment for their disease at this stage.
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Exercise after chemo: new trial tests if running and walking can keep colorectal cancer at bay
Disease control OngoingABCSG C08 is a randomized, two-arm, multicenter trial to investigate the efficacy of endurance exercise following adjuvant chemotherapy in patients with colorectal cancer. Indication: Locally advanced colorectal cancer after adjuvant chemotherapy. Evidence supporting the benefic…
Phase: NA • Sponsor: Austrian Breast & Colorectal Cancer Study Group • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC